Envoy Medical (NASDAQ:COCHW – Get Free Report) is anticipated to post its results before the market opens on Thursday, November 5th. Analysts expect Envoy Medical to announce earnings of ($0.6733) per share and revenue of $0.09 million for the quarter.
Envoy Medical Trading Down 0.7%
Shares of NASDAQ COCHW traded down $0.00 during mid-day trading on Tuesday, hitting $0.03. The company had a trading volume of 2,322 shares, compared to its average volume of 25,885. Envoy Medical has a 12 month low of $0.02 and a 12 month high of $0.10. The firm’s 50 day simple moving average is $0.04 and its two-hundred day simple moving average is $0.05.
About Envoy Medical
Envoy Medical is a medical technology company focused on developing fully implanted hearing devices for people with hearing loss. The company’s technologies are designed to use the body’s natural anatomy to capture sound and deliver auditory stimulation, with the goal of providing hearing restoration without the external components required by many conventional hearing devices.
Envoy Medical’s lead product is the Acclaim cochlear implant, a fully implanted device intended for adults with sensorineural hearing loss who may benefit from cochlear implantation.
Read More
- Five stocks we like better than Envoy Medical
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
- Republic Services Has the Momentum, But Waste Management Has Another Advantage
- Alphabet’s Golden Dome Talks Could Open a New Market, But How Much Is at Stake?
- Tempus AI Surges on Earnings Beat, But Can the Rally Last?
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
